Amaral E, Foreman T, Namasivayam S, Hilligan K, Kauffman K, Barbosa Bomfim C, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219: pubmed publisher

Lehman N, Kowalska W, Zarobkiewicz M, Mazurek M, Mrozowska K, Bojarska Junak A, et al. Pro- vs. Anti-Inflammatory Features of Monocyte Subsets in Glioma Patients. Int J Mol Sci. 2023;24: pubmed publisher

Zhu M, Zhang H, Pedersen K, Foster N, Jaszewski B, Liu X, et al. Understanding Suboptimal Response to Immune Checkpoint Inhibitors. Adv Biol (Weinh). 2023;7:e2101319 pubmed publisher

Lucien F, Kim Y, Qian J, Orme J, Zhang H, Arafa A, et al. Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity. Int J Radiat Oncol Biol Phys. 2022;114:725-737 pubmed publisher

Vera Aguilera J, Paludo J, McWilliams R, Zhang H, Li Y, Kumar A, et al. Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients. Melanoma Res. 2020;30:364-375 pubmed publisher

Yan Y, Cao S, Liu X, Harrington S, Bindeman W, Adjei A, et al. CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy. JCI Insight. 2018;3: pubmed publisher